STRATEGIES FOR SUCCESSFUL IMPLEMENTATION & SUPPORT OF MEDICAL COMMUNICATION IN EMERGING MARKETS

Emerging markets are an area of significant interest for life science manufacturers as they present a unique opportunity to fulfill unmet medical needs for patients around the world. Medical communications are an effective method of conveying scientific information to healthcare providers, payers and patients based on their important unanswered questions around efficacy, safety, health outcomes, and other key areas of interest. Medical communication teams focused on emerging markets have the exciting and challenging task of planning and developing scientific disclosures that satisfy and align with the unique cultural and geographic parameters within and across countries and regions in emerging markets.

• Utilizing local insights and resources to add value
• Integrating language and cultural distinctions in strategy development
• Compliance and process considerations

Speaker:

Renee Granger, PhD
Consultant, Global Scientific Communications – Emerging Markets
Eli Lilly Australia Pty Ltd

Contact:

Brooke Akins | Division Director, Life Science Programs
+1 (312) 224-1693 | bakins@q1productions.com​